// App-Quantinova.ai

2613 : MEK is a therapeutic and chemopreventative target in squamous cell carcinoma

Researchers

Presenter

  • Charles H. Adelmann

Principal Investigators

  • Kimberly Truong

  • Roger Liang

  • Varun Bansal

  • Rachael Saporito

  • Woojin Lee

  • Lili Du

  • Courtney Nicholas

  • Marco Napoli

  • Elsa R. Flores

  • Kenneth Y. Tsai

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

Disease

  • Cutaneous squamous cell carcinoma

  • keratosis

  • Solid malignancies

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

  • Extracellular signal-regulated kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved